Clinical Coverage/Medical Policy Updates
Arkansas Total Care updates select clinical policies each month. This page reflects clinical and medical policy changes. We review all policies annually.
Please refer to this page for recent policy updates. Please reach out to your Provider Relations representative if you have any questions.
CP.BH.500 BH Treatment Documentation Requirements (PDF)
CP.MP.116 Lysis of Epidural Lesions (PDF)
CP.MP.147 Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF)
CP.MP.188 Pediatric Oral Function Therapy (PDF)
CP.MP.210 Repair of Nasal Valve Compromise (PDF)
CP.MP.244 Liposuction for Lipedema (PDF)
CP.MP.24 Multiple Sleep Latency Testing (PDF)
CP.MP.87 Therapeutic Utilization of Inhaled Nitric Oxide (PDF)
CP.MP.91 Obstetrical Home Care Programs (PDF)
CP.MP.40 Gastric Electrical Stimulation (PDF)
CP.MP.91 OB Home Programs (PDF)
CP.MP.141 Non-Myeloablative Allogeneic Stem Cell Transplants (PDF)
V2.2024 CG Hereditary Cancer Susceptibility (PDF)
V2.2024 CG Immune, Autoimmune, and Rheumatoir Disorders (PDF)
V2.2024 CG Kidney Disorders (PDF)
V2.2024 CG Lung Disorders (PDF)
V2.2024 CG Metabolic, Endocrine and Mitochondrial Disorders (PDF)
V2.2024 CG Multisystem Inherited Disorders, ID and Developmental Delay (PDF)
V2.2024 CG Non-invasive Prenatal Screening (PDF)
V2.2024 CG Oncology Algorithmic Testing (PDF)
V2.2024 CG Oncology Cancer Screening (PDF)
V2.2024 CG Oncology Circ Tumor DNA Tumor Cells Liquid Biopsy (PDF)
V2.2024 CG Oncology Cytogenetic Testing (PDF)
V2.2024 CG Oncology Molecular Analysis of Solid Tumor and Hem Malignancies (PDF)
V2.2024 CG Pharmacogenetics (PDF)
V2.2024 CG Preimplantation Genetic Testing (PDF)
V2.2024 CG Prenatal and Preconception Carrier Screening (PDF)
V2.2024 CG Prenatal Dx of Amnio CVS or PUBS and Pregnancy Loss (PDF)